The Novo Nordisk Prize is an annual award presented to acknowledge exceptional contributions within the fields of medical and health sciences.
[1][2] It is specifically aimed at individuals who have demonstrated outstanding research or innovation that has the potential to advance medical science, particularly in areas related to diabetes, endocrinology, and biopharmaceutical science.
The Foundation holds a controlling interest in the Danish pharmaceutical firm Novo Nordisk.
Alongside the financial component, recipients are also awarded a medal and a diploma in recognition of their contributions.
The prize is designed not only to honour exceptional scientific work but also to support the continued research efforts of the recipients.